Natures Willow Balm Pain Relieving Patch

Harpagophytum Procumbens, Arnica Montana, Boswellia Serrata, Salix Alba


Wb Ventures Llc
Human Otc Drug
NDC 73498-023
Natures Willow Balm Pain Relieving Patch also known as Harpagophytum Procumbens, Arnica Montana, Boswellia Serrata, Salix Alba is a human otc drug labeled by 'Wb Ventures Llc'. National Drug Code (NDC) number for Natures Willow Balm Pain Relieving Patch is 73498-023. This drug is available in dosage form of Patch. The names of the active, medicinal ingredients in Natures Willow Balm Pain Relieving Patch drug includes Arnica Montana Flower - 3 mg/1 Harpagophytum Procumbens Root - 19 mg/1 Indian Frankincense - 1 mg/1 Salix Alba Bark - .5 mg/1 . The currest status of Natures Willow Balm Pain Relieving Patch drug is Active.

Drug Information:

Drug NDC: 73498-023
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Natures Willow Balm Pain Relieving Patch
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Harpagophytum Procumbens, Arnica Montana, Boswellia Serrata, Salix Alba
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Wb Ventures Llc
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Patch
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:ARNICA MONTANA FLOWER - 3 mg/1
HARPAGOPHYTUM PROCUMBENS ROOT - 19 mg/1
INDIAN FRANKINCENSE - 1 mg/1
SALIX ALBA BARK - .5 mg/1
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:TOPICAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 21 Apr, 2021
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 10 May, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:WB Ventures LLC
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UPC:0860005199815
UPC stands for Universal Product Code.
UNII:OZ0E5Y15PZ
1OYM338E89
4PW41QCO2M
205MXS71H7
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
73498-023-016 POUCH in 1 BOX (73498-023-01) / 1 PATCH in 1 POUCH21 Apr, 2021N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Purpose purpose* trauma, muscle pain and stiffness

Product Elements:

Natures willow balm pain relieving patch harpagophytum procumbens, arnica montana, boswellia serrata, salix alba vanillyl butyl ether helichrysum italicum flower oil arnica montana flower arnica montana flower camphor (natural) phenoxyethanol water dehydroacetic acid ethylhexylglycerin benzoic acid polysorbate 60 butyl acrylate/methyl methacrylate/methacrylic acid copolymer (18000 mw) salix alba bark salix alba bark harpagophytum procumbens root harpagophytum procumbens root lavender oil peppermint oil propylene glycol indian frankincense indian frankincense glycerin eucalyptus oil geranium oil, algerian type

Indications and Usage:

Uses uses* for the temporary relief of minor aches and pains of muscles and joints associated with simple backache arthritis strains

Warnings:

Warnings for external use only. do not use on wounds or damaged skin with a heating pad if you are allergic to any ingredients in this product when using this product use only as directed avoid contact with eyes or mucous membranes do not bandage tightly stop use and ask a doctor if burning, itching or excessive skin irritation occurs condition worsens symptoms persist for more than 3 days or clear up and occur again within a few days if pregnant or breast-feeding, ask a health professional before use.

Dosage and Administration:

Directions adults and children over 12 years of age: clean and dry affected area open pouch and remove patch. if desired, cut patch to size remove transparent film from patch and apply to affected area for up to 8 hours apply to affected area not more than 3 to 4 times daily children under 12 years of age: consult a physician

Package Label Principal Display Panel:

Package labels box label pouch label

Further Questions:

Questions or comments? 1-888-609-4556


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.